A method and kit for detection of Mycobacterium Avium Subspecies Paratuberculosis (MAP) in blood and blood derivative samples from humans by culture and PCR. Technology can screen for MAP in blood samples from millions of patients having inflammatory and non-inflammatory bowel diseases, and the results are used to identify those patients with MAP for treatment by antibiotics. The method and kit can monitor and evaluate the outcome of therapy.